EMJ GOLD - European Medical Journal

Pharma News, Views & Analysis

Filter Advertise With Us

FDA removes hurdle to CAR T-cell therapies

The body is eliminating of Risk Evaluation and Mitigation Strategies for all currently approved BCMA- and CD19-directed CAR T-cell therapies.

UK clinical trial diversity needs work, finds ABPI

New Ipsos data shows that while 58% of UK adults are willing to join clinical trials, this drops to 41% among ethnic minority adults.

UK to raise branded drug repayment rate to over 30%

The UK will hike statutory payment rates for branded drugs to over 30% in 2025, far surpassing other European markets and raising concerns.

Social media key to Gen Z pharma hires, says ABPI

According to new research from the ABPI, pharma companies need to modernise their outreach strategies.

Vantive to invest $1bn in digital kidney care therapies

Vantive has announced the five-year, major investment to expand its R&D and manufacturing capabilities.

Two men walking on arrows

Sanofi to acquire Blueprint in $9.1bn deal

Sanofi is set to acquire Blueprint Medicines, a US-based biopharmaceutical company specialising in systemic mastocytosis.

King’s Fund sheds light on access to medicine in UK

The King’s Fund in the UK has released an updated explainer on the availability of new medicines in the UK’s NHS.

Kyron.bio lands €5.5m to refine biologic drug design

The Paris biotech aims to improve biologic drugs by mastering glycan control, aiming for safer, more effective therapies.

The word spotlight on a blue background

Spotlight: May 2025

Catch up on May’s key pharma news, research updates and policy shifts.

Loading posts...

« Previous 1 2 3 4 … 30 Next »